Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8738759rdf:typepubmed:Citationlld:pubmed
pubmed-article:8738759lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8738759lifeskim:mentionsumls-concept:C0031327lld:lifeskim
pubmed-article:8738759lifeskim:mentionsumls-concept:C0150055lld:lifeskim
pubmed-article:8738759lifeskim:mentionsumls-concept:C0025605lld:lifeskim
pubmed-article:8738759pubmed:issue3lld:pubmed
pubmed-article:8738759pubmed:dateCreated1996-10-25lld:pubmed
pubmed-article:8738759pubmed:abstractTextTen patients with chronic pain were randomized to an open, balanced, crossover study. Each patients received two different preparations of racemic methadone, i.e., tablets and intravenous infusion. The pharmacokinetic parameters of the R- and S-enantiomers of the racemate are reported. The analgesically active R-methadone has a significantly longer mean elimination half-life than the optical antipode S-methadone (t1/2 = 37.5 and 28.6 h, respectively). The mean total volume of distribution is 496.6 L for R-methadone and 289.1 L for S-methadone. Significant differences in the mean clearance between R- and S-methadone are seen (0.158 and 0.129 L/min, respectively). However, the lagtime after oral administration and the bioavailability did not show differences between the isomers. The data suggest that both enantiomers of methadone should be measured if correlations between pharmacodynamics and kinetics are made due to the stereoselective differences in half-life, total volume of distribution, and clearance.lld:pubmed
pubmed-article:8738759pubmed:languageenglld:pubmed
pubmed-article:8738759pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8738759pubmed:citationSubsetIMlld:pubmed
pubmed-article:8738759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8738759pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8738759pubmed:statusMEDLINElld:pubmed
pubmed-article:8738759pubmed:monthJunlld:pubmed
pubmed-article:8738759pubmed:issn0163-4356lld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:KristensenKKlld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:RasmussenS...lld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:AngeloH RHRlld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:ChristrupL...lld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:SjøgrenPPlld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:DrenckN ENElld:pubmed
pubmed-article:8738759pubmed:authorpubmed-author:BlemmerTTlld:pubmed
pubmed-article:8738759pubmed:issnTypePrintlld:pubmed
pubmed-article:8738759pubmed:volume18lld:pubmed
pubmed-article:8738759pubmed:ownerNLMlld:pubmed
pubmed-article:8738759pubmed:authorsCompleteYlld:pubmed
pubmed-article:8738759pubmed:pagination221-7lld:pubmed
pubmed-article:8738759pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:meshHeadingpubmed-meshheading:8738759-...lld:pubmed
pubmed-article:8738759pubmed:year1996lld:pubmed
pubmed-article:8738759pubmed:articleTitleStereoselective pharmacokinetics of methadone in chronic pain patients.lld:pubmed
pubmed-article:8738759pubmed:affiliationDepartment of Pharmaceutics, Royal Danish School of Pharmacy, Copenhagen, Denmark.lld:pubmed
pubmed-article:8738759pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8738759pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8738759pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8738759pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:8738759pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8738759lld:pubmed